Neurocrine biosciences to host analyst day on december 5, 2023

San diego , dec. 1, 2023 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix), a leading neuroscience-focused biopharmaceutical company, will hold its analyst day focused on its r&d portfolio and strategy on tuesday, december 5, 2023 in new york. the event will be held in-person and via webcast.

NBIX Ratings Summary

NBIX Quant Ranking